Oncoresponse
OncoResponse is a clinical stage, privately held immuno-oncology biotech company developing cancer immunotherapies using clues from the immune systems of elite cancer responders. In a broad strategic alliance with MD Anderson Cancer Center, OncoResponse deploys a proprietary B-cell discovery platform to identify and develop novel therapeutics targeting the tumor microenvironment. The company’s lead candidate, OR2805, has entered clinical studies with a unique and transformative approach to the advancement of cancer therapeutics. OncoResponse is based in Houston, Texas and Seattle, Washington.
7-day free trial · no credit card
Verified contacts
11
available on Kipplo
LinkedIn employees
11
11 to 50 range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
1
tools in use
Monthly traffic
32
organic / mo
Sign up free to see all 11 verified contacts at Oncoresponse
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
11 contacts with verified email or phone · masked until revealed.
- CR
Chris Russell
Chief Financial Officer · Other
EmailPhone - CS
Clifford Stocks
() · Other
EmailPhone - KD
Kamal D. Puri
() · Other
EmailPhone - MB
Myriam Bouchlaka
Director Immuno-oncology · Other
EmailPhone - CZ
Cisco Zapata
Associate Scientist · Science
EmailPhone - DS
Doug Spicer
Scientist Ii · Science
EmailPhone - GN
Gajendra Naika
Scientist Ii · Science
EmailPhone - PP
Peter Probst
- Ä · Other
EmailPhone
Showing 8 of 11 verified contacts
Top roles at Oncoresponse
7 distinct titles indexed · top 7 shown.
- 2()
- 2scientist ii
- 1- ä
- 1associate scientist
- 1chief financial officer
- 1director immuno-oncology
- 1research associate i
Sign up to unlock all 11 contacts at Oncoresponse
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 11 verified contacts at Oncoresponse
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.